WeVote
Log In

Bill

Bill

SB 160

Regards prescription drugs and medication switching

136th Legislature (2025-2026) Introduced by Terry Johnson and 1 co-sponsor

SB 160 establishes Ohio rules for when and how patients' prescribed medications can be substituted or switched to alternative drugs by pharmacies or insurers.

Introduced
#commerce #healthcare #healthandhumanservices #insurance
0
WeVote Research Nonpartisan
Bill Summary · SB 160

Legislative bill overview

SB 160 addresses prescription drug switching and medication management practices in Ohio. The bill establishes rules governing how pharmacists, insurers, or other entities can substitute or switch patients from their prescribed medications to alternative drugs. It aims to balance cost containment with patient safety and prescriber authority.

Why is this important

Medication switching directly affects patient health outcomes, treatment costs, and the doctor-patient relationship. Unauthorized or inappropriate substitutions can lead to therapeutic failures, adverse reactions, or unnecessary hospitalizations. This bill clarifies the legal framework for a common healthcare practice that impacts thousands of Ohioans daily.

Potential points of contention

  • Prescriber authority vs. cost control: Debate over whether insurers should have authority to override physician-selected medications for cost savings, or if prescriber choice takes precedence
  • Patient notification requirements: Disagreement on what notice patients must receive before medication switching and whether they can easily object
  • Coverage definitions: Disputes over which medication changes constitute "switching" versus legitimate substitutions (brand-to-generic, therapeutic alternatives within same drug class)

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.